Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline

Bibliographic Details
Main Authors:	Justin Bauzon, Garam Lee, Jeffrey Cummings
Format:	Article
Language:	English
Published:	BMC 2023-08-01
Series:	Alzheimer’s Research & Therapy
Online Access:	https://doi.org/10.1186/s13195-023-01284-9

Similar Items

Who funds Alzheimer's disease drug development?
by: Jeffrey Cummings, et al.
Published: (2021-01-01)

Alzheimer's disease drug development pipeline: 2021
by: Jeffrey Cummings, et al.
Published: (2021-01-01)

Alzheimer's disease drug development pipeline: 2023
by: Jeffrey Cummings, et al.
Published: (2023-04-01)

Alzheimer's disease drug development pipeline: 2022
by: Jeffrey Cummings, et al.
Published: (2022-01-01)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
by: Shivani Kumar, et al.
Published: (2017-10-01)

A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer’s Disease
by: Alvaro Esteban-Martos, et al.
Published: (2023-07-01)

Single-cell-led drug repurposing for Alzheimer’s disease
by: Silvia Parolo, et al.
Published: (2023-01-01)

Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer’s Disease
by: Georgios N. Dimitrakopoulos, et al.
Published: (2023-10-01)

The Potential of a Stratified Approach to Drug Repurposing in Alzheimer’s Disease
by: Chloe Anderson, et al.
Published: (2023-12-01)

Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease
by: Muna A. Adem, et al.
Published: (2024-01-01)

Network-based stage-specific drug repurposing for Alzheimer’s disease
by: Kyriaki Savva, et al.
Published: (2022-01-01)

Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer’s Disease
by: Márcia Martins, et al.
Published: (2020-09-01)

Repurposing of Tibolone in Alzheimer’s Disease
by: George E. Barreto
Published: (2023-07-01)

Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood
by: Marilena M. Bourdakou, et al.
Published: (2023-11-01)

Systematic identification of risk factors and drug repurposing options for Alzheimer's disease
by: Chong Wu, et al.
Published: (2021-01-01)

Repurposing old drugs as antiviral agents for coronaviruses
by: Cheng-Wei Yang, et al.
Published: (2020-08-01)

Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease
by: Kyriaki Savva, et al.
Published: (2023-04-01)

Identification of Potential Repurposable Drugs in Alzheimer’s Disease Exploiting a Bioinformatics Analysis
by: Giulia Fiscon, et al.
Published: (2022-10-01)

An in silico drug repurposing pipeline to identify drugs with the potential to inhibit SARS-CoV-2 replication
by: Méabh MacMahon, et al.
Published: (2023-01-01)

ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs
by: Bing He, et al.
Published: (2023-02-01)

An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis
by: Luca Menestrina, et al.
Published: (2022-12-01)

Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer’s Disease, Lithium, and Autophagy
by: Odeya Damri, et al.
Published: (2020-12-01)

Synthesize heterogeneous biological knowledge via representation learning for Alzheimer’s disease drug repurposing
by: Kang-Lin Hsieh, et al.
Published: (2023-01-01)

An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma
by: Seán B. Lyne, et al.
Published: (2021-04-01)

Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review
by: Shafina Siddiqui, et al.
Published: (2022-08-01)

Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent
by: Lu Yu, et al.
Published: (2023-04-01)

High-throughput target trial emulation for Alzheimer’s disease drug repurposing with real-world data
by: Chengxi Zang, et al.
Published: (2023-12-01)

Drug repurposing for Alzheimer’s disease from 2012–2022—a 10-year literature review
by: Monika E. Grabowska, et al.
Published: (2023-09-01)

Repurposing pipelines for hydrogen: Legal and policy considerations
by: Suriya Evans-Pritchard Jayanti
Published: (2022-12-01)

A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures
by: Marika Mokou, et al.
Published: (2020-11-01)

Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis
by: Megan Truong, et al.
Published: (2018-05-01)

Drug Repurposing in the Chemotherapy of Infectious Diseases
by: Amal Hamid, et al.
Published: (2024-01-01)

Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer’s disease with real-world clinical validation
by: Chao Yan, et al.
Published: (2024-02-01)

Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment
by: Line Séguy, et al.
Published: (2021-10-01)

Hybrid neural network approaches to predict drug–target binding affinity for drug repurposing: screening for potential leads for Alzheimer’s disease
by: Xialin Wu, et al.
Published: (2023-06-01)

Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer’s Disease Patients and In Silico Prediction of Potential Repurposable Drugs
by: Paolo Fagone, et al.
Published: (2022-04-01)

Trilogy of drug repurposing for developing cancer and chemotherapy-induced heart failure co-therapy agent
by: Xin Chen, et al.
Published: (2024-02-01)

A genetically supported drug repurposing pipeline for diabetes treatment using electronic health recordsResearch in context
by: Megan M. Shuey, et al.
Published: (2023-08-01)

COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
by: Chow Suet-May, et al.
Published: (2022-12-01)

The development of an automated machine learning pipeline for the detection of Alzheimer’s Disease
by: Nicholas Chedid, et al.
Published: (2022-10-01)